* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
|CAT#||Product Name||M.W||Molecular Formula||Inquiry|
|CAD-067||Tau Peptide (307-321)||1705.03||C₇₈H₁₃₃N₁₉O₂₃||Inquiry|
|Q0701||(Asn670,Sta671,Val672)-Amyloid β/A4 Protein Precursor770(662-675)||1651.83||Inquiry|
|Q0816||Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770(668-675)-Lys(DABCYL)-Arg||2005.25||Inquiry|
The Aβ region of APP contains a sequence of 42-43 amino acid residues, partially located in the extracellular domain and partially in the transmembrane domain of APP. APP is cleaved by three types of proteases, called α-,β-and γ-secretase. Proteolytic cleavage of amyloid from amyloid precursor (APP) by APP secretase is a key event in the pathogenesis of Alzheimer’s disease (AD). The α-secretase cleaves APP within the amyloid sequence, while the β- and γ-secretase cleave at the N- and C-termini, respectively. The transmembrane aspartyl protease BACE has been identified as a beta-secretase, and several proteases (ADAM-10, TACE, PC7) may be α-secretase. β-secretase and γ-secretase are involved in the production of β-amyloid components in senile plaques in the brains of patients with Alzheimer's disease, and have driven the main research work to design these selective protease inhibitors. Interestingly, γ-secretase cleaves several proteins, including Notch, E-cadherin, CD44 and ErbB-4 (erythroblast leukemia virus oncogene homolog 4), which are important regulators of angiogenesis. The β-amyloid precursor protein, which is cleaved by β-secretase and γ-secretase to produce β-amyloid, is highly expressed in the endothelium of neovascularization, suggesting that it may play a role in angiogenesis.
The researchers further explored the effects of different structures of beta and γ-secretase inhibitors on angiogenesis and tumor growth. Both gamma and beta-secretase inhibitors tested reduced endothelial cell proliferation without inducing cytotoxicity, inhibited the formation of capillary structures in vitro, and inhibited the sprouting of microvascular growth in the rat aortic ring model of angiogenesis. Furthermore, they effectively inhibit the growth and angiogenesis of human glioblastoma and human lung adenocarcinoma tumors xenografted into nude mice.
Many studies have shown that presenilin may be gamma-secretase, although this remains to be confirmed. Inhibition of β- and γ-secretase, or stimulation of α-secretase, is a reasonable strategy for AD treatment intervention. A series of data suggest that γ and β-secretase play important roles in angiogenesis, and that inhibitors of γ and β-secretase can constitute a new class of anti-angiogenic and anti-tumor compounds.